SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Loftus Daniel R

(Last) (First) (Middle)
4500 DORR STREET

(Street)
TOLEDO OH 43615

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
HEALTH CARE REIT INC /DE/ [ HCN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Senior Vice President
3. Date of Earliest Transaction (Month/Day/Year)
03/23/2012
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/23/2012 M 8,069 A $40.83 45,944.34 D
Common Stock 03/23/2012 M 3,516 A $37 49,460.34 D
Common Stock 03/26/2012 M 5,793 A $37 55,253.34 D
Common Stock 03/23/2012 S 5,793 D $54.25 49,460.34 D
Common Stock 03/23/2012 S 5,792 D $54.1 43,668.34 D
Common Stock 03/26/2012 S 5,793 D $54.48 37,875.34 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option (Right to Buy) $40.83 03/23/2012 M 8,069(1) 01/15/2009 01/21/2018 Common 10,085(1) $0.00(2) 2,016 D
Option (Right to Buy) $37 03/23/2012 M 3,516(3) 01/15/2010 01/29/2019 Common 15,514(3) $0.00(2) 11,998 D
Option (Right to Buy) $37 03/26/2012 M 5,793(3) 01/15/2011 01/29/2019 Common 11,998(3) $0.00(2) 6,205 D
Explanation of Responses:
1. Options for the purchase of 10,085 shares of common stock at $40.83 per share were granted to Mr. Loftus on January 21, 2008, which grant has previously been reported. Options for the purchase of 2,018 shares vested on January 15, 2009, options for the purchase of 2,017 shares vested on January 15 of each 2010, 2011 and 2012 and options for the purchase of 2,016 shares will vest on January 15, 2013.
2. The options were granted under the Health Care REIT, Inc. 2005 Long-Term Incentive Plan and had no acquisition price.
3. Options for the purchase of 15,514 shares of common stock at $37.00 per share were granted to Mr. Loftus on January 29, 2009, which grant has previosly been reported. Options for the purchase of 3,103 shares vested on January 15 of each of 2010, 2011 and 2012, options for the purchase of 3,103 shares will vest on January 15, 2013 and options for the purchase of 3,102 shares will vest on January 15, 2014.
Remarks:
By: Erin C. Ibele Attorney-in-Fact For: Daniel R. Loftus 03/27/2012
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.